Back to Trades
Kewalramani Reshma
CEO & PresidentDirectorCIK 0001735944
Profile
- Filings
- 7
- Buy transactions
- 2
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Kewalramani Reshma, CEO & President, Director, accounts for 7 disclosed filings worth $26.0M, all concentrated in VERTEX PHARMACEUTICALS INC / MA (VRTX), active 2025–2026. The record is a roughly balanced mix of buying and selling, with $3.9M in purchases against $6.3M in sales. The largest single open-market purchase on record is $3.9M in VERTEX PHARMACEUTICALS INC / MA. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Nov 10 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Sell | $6.3M |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Tax withheld | $2.4M |
| Feb 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Grant | $3.2M |
| Feb 18 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Tax withheld | $6.4M |
| Feb 12 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Tax withheld | $3.9M |
| Jan 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Grant | $0 |
| Aug 7 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Buy | $3.9M |
7 filings